Related Experiment Video

Updated: May 28, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Erk1 positively regulates osteoclast differentiation and bone resorptive activity

Yongzheng He1, Karl Staser, Steven D Rhodes

  • 1Departments of Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.

Plos One
|October 1, 2011
PubMed

Insights

Extracellular signal-regulated kinases (ERK1 and 2) impact bone development. Erk1 specifically enhances osteoclast function and bone resorption, suggesting its potential as a therapeutic target for bone diseases.

Area of Science:

  • Cell Biology
  • Skeletal Biology
  • Molecular Signaling

Background:

  • Extracellular signal-regulated kinases (ERK1 and 2) are crucial signaling molecules involved in cell proliferation, survival, differentiation, and protein synthesis.
  • Dysregulated ERK signaling is implicated in genetic disorders with skeletal abnormalities, such as Noonan syndrome and Neurofibromatosis type 1.
  • Osteoclasts, derived from macrophage/monocyte lineages, are key cells responsible for bone resorption.

Purpose of the Study:

  • To investigate the role of Erk1 and Erk2 in osteoclast development and function.
  • To determine the impact of Erk1 and Erk2 disruption on bone resorption and overall bone mineral density.

Main Methods:

  • Genetic disruption of Erk1 and Erk2 in mice.
  • Assessment of osteoclast progenitor cell numbers and differentiation.
  • Evaluation of osteoclast bone resorptive activity, including pit formation assays.
  • Analysis of M-CSF-mediated adhesion and migration.
  • Bone marrow transplantation experiments using wild-type (WT), Erk1(-/-), and Erk2(-/-) bone marrow mononuclear cells (BMMNCs).

Main Results:

  • Genetic disruption of Erk1 significantly reduced osteoclast progenitor cell numbers.
  • Erk1 deficiency impaired osteoclast pit formation and diminished M-CSF-mediated adhesion and migration.
  • Mice reconstituted with Erk1(-/-) BMMNCs exhibited increased bone mineral density compared to recipients of WT or Erk2(-/-) BMMNCs.
  • These findings highlight a marrow-autonomous, Erk1-dependent role in osteoclast function.

Conclusions:

  • Erk1 plays a significant role in regulating osteoclast development and bone resorptive activity.
  • Erk1-dependent osteoclast function is critical for maintaining normal bone mineral density.
  • Erk1-specific inhibitors may represent a therapeutic strategy for modulating aberrant osteoclast function in bone-related diseases.

More Related Videos

Isolation, Purification, and Differentiation of Osteoclast Precursors from Rat Bone Marrow11:11

Isolation, Purification, and Differentiation of Osteoclast Precursors from Rat Bone Marrow

Published on: May 19, 2019

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.